Tanja Keiper, molecular biologist by training, holds a doctoral thesis in internal medicine and is since 2005 working in the healthcare industry in various positions in R&D. She joined Merck KGaA in 2007 and is since 2014 member of Global Clinical Operations External Innovation/Clinical Applications & Innovation, focusing on patient centricity and innovation in clinical development. Tanja has shown her expertise in patient centricity/patient engagement in TransCelerate and IMI projects.